Sartorius Stedim Biotech S.A. Statistics Share Statistics Sartorius Stedim Biotech S.A. has 97.3M
shares outstanding. The number of shares has increased by -0.02%
in one year.
Shares Outstanding 97.3M Shares Change (YoY) -0.02% Shares Change (QoQ) -0.02% Owned by Institutions (%) n/a Shares Floating 25.65M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 35.29K, so 0% of the outstanding
shares have been sold short.
Short Interest 35.29K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 32.41
Valuation Ratios The PE ratio is 104.08 and the forward
PE ratio is 34.94.
Sartorius Stedim Biotech S.A.'s PEG ratio is
-2.26.
PE Ratio 104.08 Forward PE 34.94 PS Ratio 6.56 Forward PS 4 PB Ratio 4.57 P/FCF Ratio 38.34 PEG Ratio -2.26
Financial Ratio History Enterprise Valuation Sartorius Stedim Biotech S.A. has an Enterprise Value (EV) of 20.41B.
EV / Sales 7.34 EV / EBITDA 30.45 EV / EBIT 25.05 EV / FCF 42.95
Financial Position The company has a current ratio of 1.85,
with a Debt / Equity ratio of 0.72.
Current Ratio 1.85 Quick Ratio 1.12 Debt / Equity 0.72 Debt / EBITDA 4.28 Debt / FCF 6.04 Interest Coverage 2.48
Financial Efficiency Return on Equity is 4.39% and Return on Invested Capital is 4.09%.
Return on Equity 4.39% Return on Assets 2.12% Return on Invested Capital 4.09% Revenue Per Employee $279.09K Profits Per Employee $17.58K Employee Count 9,961 Asset Turnover 0.34 Inventory Turnover 2.3
Taxes Income Tax 40.7M Effective Tax Rate 18.57%
Stock Price Statistics The stock price has increased by 3.17% in the
last 52 weeks. The beta is 0.95, so Sartorius Stedim Biotech S.A.'s
price volatility has been higher than the market average.
Beta 0.95 52-Week Price Change 3.17% 50-Day Moving Average 216.1 200-Day Moving Average 205.44 Relative Strength Index (RSI) 38.35 Average Volume (20 Days) 1,196
Income Statement In the last 12 months, Sartorius Stedim Biotech S.A. had revenue of 2.78B
and earned 175.1M
in profits. Earnings per share was 1.81.
Revenue 2.78B Gross Profit 1.21B Operating Income 370.6M Net Income 175.1M EBITDA 670.5M EBIT 368.8M Earnings Per Share (EPS) 1.81
Full Income Statement Balance Sheet The company has 678.9M in cash and 2.87B in
debt, giving a net cash position of -2.19B.
Cash & Cash Equivalents 678.9M Total Debt 2.87B Net Cash -2.19B Retained Earnings 2.54B Total Assets 8.3B Working Capital 815.3M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 815.1M
and capital expenditures -339.8M, giving a free cash flow of 475.3M.
Operating Cash Flow 815.1M Capital Expenditures -339.8M Free Cash Flow 475.3M FCF Per Share 4.91
Full Cash Flow Statement Margins Gross margin is 43.41%, with operating and profit margins of 13.33% and 6.3%.
Gross Margin 43.41% Operating Margin 13.33% Pretax Margin 7.88% Profit Margin 6.3% EBITDA Margin 24.12% EBIT Margin 13.33% FCF Margin 17.1%
Dividends & Yields SDMHF pays an annual dividend of $1.5,
which amounts to a dividend yield of 0.37%.
Dividend Per Share $1.50 Dividend Yield 0.37% Dividend Growth (YoY) 2.76% Payout Ratio 63.75% Earnings Yield 0.96% FCF Yield 2.61%
Dividend Details Analyst Forecast Currently there are no analyst rating for SDMHF.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 6, 2016. It was a
forward
split with a ratio of 6:1.
Last Split Date May 6, 2016 Split Type forward Split Ratio 6:1
Scores Altman Z-Score 4.05 Piotroski F-Score 6
